甘李药业
(603087)
| 流通市值：386.20亿 | | | 总市值：410.97亿 |
| 流通股本：5.61亿 | | | 总股本：5.97亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,223,021,840.47 | 878,108,964.52 | 4,052,146,959.53 | 3,047,039,079.24 |
| 营业总成本 | 1,586,521,469.86 | 682,007,364.82 | 3,211,492,206.21 | 2,275,937,092.07 |
| 其他经营收益 | | | | |
| 营业利润 | 691,267,543.17 | 213,766,531.64 | 1,183,672,083.35 | 868,653,239.12 |
| 利润总额 | 687,102,741.41 | 212,643,078.03 | 1,229,805,744.14 | 925,710,035.08 |
| 净利润 | 609,335,274.74 | 192,462,041.72 | 1,143,583,603.28 | 818,339,617.3 |
| 每股收益 | | | | |
| 其他综合收益 | -1,511,902.56 | -565,382.71 | -973,884.42 | -406,764.76 |
| 综合收益总额 | 607,823,372.18 | 191,896,659.01 | 1,142,609,718.86 | 817,932,852.54 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,896,466,139.95 | 5,402,552,612.5 | 5,484,069,139.15 | 4,968,496,815.27 |
| 非流动资产: | | | | |
| 非流动资产合计 | 6,865,537,287.31 | 7,277,230,231.42 | 7,142,974,167.39 | 7,174,260,871.69 |
| 资产总计 | 12,762,003,427.26 | 12,679,782,843.92 | 12,627,043,306.54 | 12,142,757,686.96 |
| 流动负债: | | | | |
| 流动负债合计 | 853,374,307.01 | 676,525,886.68 | 815,786,801.63 | 690,456,931.84 |
| 非流动负债: | | | | |
| 非流动负债合计 | 199,327,503.46 | 175,125,205.71 | 182,787,340.68 | 169,908,284.09 |
| 负债合计 | 1,052,701,810.47 | 851,651,092.39 | 998,574,142.31 | 860,365,215.93 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 11,709,301,616.79 | 11,826,155,581.03 | 11,628,469,164.23 | 11,282,392,471.03 |
| 股东权益合计 | 11,709,301,616.79 | 11,828,131,751.53 | 11,628,469,164.23 | 11,282,392,471.03 |
| 负债和股东权益合计 | 12,762,003,427.26 | 12,679,782,843.92 | 12,627,043,306.54 | 12,142,757,686.96 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,233,423,222.21 | 1,100,469,222.8 | 3,984,925,452.83 | 2,960,577,867.95 |
| 经营活动现金流出小计 | 1,801,101,043.74 | 928,794,823.18 | 3,200,650,185.47 | 2,478,617,411.38 |
| 经营活动产生的现金流量净额 | 432,322,178.47 | 171,674,399.62 | 784,275,267.36 | 481,960,456.57 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,013,298,190.13 | 2,175,436,429.61 | 6,975,028,763.32 | 4,942,143,757.75 |
| 投资活动现金流出小计 | 5,048,525,986.51 | 2,430,086,326.09 | 6,939,049,472.74 | 4,610,620,481.38 |
| 投资活动产生的现金流量净额 | -35,227,796.38 | -254,649,896.48 | 35,979,290.58 | 331,523,276.37 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 153,492,162.19 | 2,000,000 | - | - |
| 筹资活动现金流出小计 | 598,192,842.08 | 241,788.6 | 737,774,345.74 | 737,269,148.6 |
| 筹资活动产生的现金流量净额 | -444,700,679.89 | 1,758,211.4 | -737,774,345.74 | -737,269,148.6 |
| 汇率变动对现金及现金等价物的影响 | -2,804,177.03 | -2,074,601.28 | 1,172,093.72 | 2,686,658.89 |
| 现金及现金等价物净增加额 | -50,410,474.83 | -83,291,886.74 | 83,652,305.92 | 78,901,243.23 |
| 期末现金及现金等价物余额 | 293,296,967.85 | 260,238,670.23 | 343,707,442.68 | 338,956,379.99 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -50,410,474.83 | - | 83,652,305.92 | - |
最新报告期：2026-09-07| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 兴业证券 | 孙媛媛,杨希成,黄翰漾 | 2.43 | 2.69 | 3.33 | 2026-09-07 |
| 东方证券 | 伍云飞 | 2.32 | 2.77 | 3.33 | 2026-09-02 |
| 长城国瑞证券 | 胡晨曦 | 2.28 | 2.78 | 3.19 | 2026-08-31 |
| 国投证券 | 冯俊曦 | 2.39 | 2.76 | 3.16 | 2026-08-27 |
| 国金证券 | 甘坛焕,马居东 | 2.40 | 2.85 | 3.45 | 2026-08-25 |